Literature DB >> 8062249

Isolation of differentially expressed sequence tags from human breast cancer.

M A Watson1, T P Fleming.   

Abstract

Identification of quantitative changes in gene expression that occur in the malignant mammary gland, if sufficiently characterized, may yield novel molecular markers which may be useful in the diagnosis and treatment of human breast cancer. Using modifications of a previously documented technique, the differential display polymerase chain reaction, we describe the isolation of differentially expressed sequence tags, short complementary DNA fragments corresponding to mRNAs that are differentially expressed in breast cancer biopsies, as compared to normal breast tissue controls. Direct sequencing and expression analysis of two sequence tags demonstrate that they represent sequences which are overexpressed in a number of breast carcinoma cell lines. A paradigm for generating a catalogue of these sequence tags is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8062249

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

Review 1.  The promise of transcription profiling for understanding the pathogenesis of scleroderma.

Authors:  D R Strehlow
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

2.  Identification of immunodominant HLA-B7-restricted CD8+ cytotoxic T cell epitopes derived from mammaglobin-A expressed on human breast cancers.

Authors:  Haseeb Ilias Basha; Venkataswarup Tiriveedhi; Timothy P Fleming; William E Gillanders; T Mohanakumar
Journal:  Breast Cancer Res Treat       Date:  2010-06-11       Impact factor: 4.872

3.  Cataloging altered gene expression in young and senescent cells using enhanced differential display.

Authors:  M H Linskens; J Feng; W H Andrews; B E Enlow; S M Saati; L A Tonkin; W D Funk; B Villeponteau
Journal:  Nucleic Acids Res       Date:  1995-08-25       Impact factor: 16.971

4.  Mammaglobin-A immunohistochemistry in primary central nervous system neoplasms and intracranial metastatic breast carcinoma.

Authors:  Patrick J Cimino; Richard J Perrin
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-07

5.  Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer.

Authors:  Venkataswarup Tiriveedhi; Natalia Tucker; John Herndon; Lijin Li; Mark Sturmoski; Matthew Ellis; Cynthia Ma; Michael Naughton; A Craig Lockhart; Feng Gao; Timothy Fleming; Peter Goedegebuure; Thalachallour Mohanakumar; William E Gillanders
Journal:  Clin Cancer Res       Date:  2014-12-01       Impact factor: 12.531

6.  Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens.

Authors:  Lijin Li; John M Herndon; Steven M Truscott; Ted H Hansen; Timothy P Fleming; Peter Goedegebuure; William E Gillanders
Journal:  Vaccine       Date:  2010-02-23       Impact factor: 3.641

7.  Relationship between molecular subtype of invasive breast carcinoma and expression of gross cystic disease fluid protein 15 and mammaglobin.

Authors:  Gloria H Lewis; Andrea Proctor Subhawong; Hind Nassar; Russell Vang; Peter B Illei; Ben Ho Park; Pedram Argani
Journal:  Am J Clin Pathol       Date:  2011-04       Impact factor: 2.493

8.  Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells.

Authors:  Venkataswarup Tiriveedhi; Timothy P Fleming; Peter S Goedegebuure; Michael Naughton; Cynthia Ma; Craig Lockhart; Feng Gao; William E Gillanders; T Mohanakumar
Journal:  Breast Cancer Res Treat       Date:  2012-06-08       Impact factor: 4.872

9.  Relationship between mammaglobin expression and estrogen receptor status in breast tumors.

Authors:  Xiao-feng Guan; Mohammad K Hamedani; Adewale Adeyinka; Christina Walker; Angela Kemp; Leigh C Murphy; Peter H Watson; Etienne Leygue
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

10.  Identification and translational validation of novel mammaglobin-A CD8 T cell epitopes.

Authors:  S D Soysal; S Muenst; J Kan-Mitchell; E Huarte; X Zhang; I Wilkinson-Ryan; T Fleming; V Tiriveedhi; T Mohanakumar; L Li; J Herndon; D Oertli; S P Goedegebuure; W E Gillanders
Journal:  Breast Cancer Res Treat       Date:  2014-09-12       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.